Additional oligofructose/inulin does not increase faecal bifidobacteria in critically ill patients receiving enteral nutrition: a randomised controlled trial

Majid HA 1 , Cole J 2 , Emery PW 2 , Whelan K 2

Affiliations 

  • 1 King's College London, School of Medicine, Diabetes and Nutritional Sciences Division, London, UK; University of Malaya, Department of Social and Preventive Medicine, Kuala Lumpur, Malaysia. Electronic address: hazreen.abdulmajid@gmail.com
  • 2 King's College London, School of Medicine, Diabetes and Nutritional Sciences Division, London, UK
Clin Nutr, 2014 Dec;33(6):966-72.
PMID: 24290345 DOI: 10.1016/j.clnu.2013.11.008

Abstract

Patients with diarrhoea during enteral nutrition (EN) have been shown to have low faecal bifidobacteria concentrations. Oligofructose/inulin selectively stimulate the growth of bifidobacteria in healthy humans. This study investigates the effect of additional oligofructose/inulin on the gastrointestinal microbiota, short-chain fatty acids (SCFA) and faecal output in patients receiving EN.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications